List of Kala Pharmaceuticals patents

Patents where

Current Assignee

Name

Kala Pharmaceuticals

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9580421 Urea derivatives and uses thereof	Patent 9580421 was granted and assigned to Kala Pharmaceuticals on February, 2017 by the United States Patent and Trademark Office.	Kala Pharmaceuticals	Kala Pharmaceuticals	United States Patent and Trademark Office	9580421	February 28, 2017
‌ US Patent 11318088 Compositions and methods utilizing poly(vinyl alcohol) and/or other polymers that aid particle transport in mucus	Patent 11318088 was granted and assigned to Kala Pharmaceuticals on May, 2022 by the United States Patent and Trademark Office.	Kala Pharmaceuticals	Kala Pharmaceuticals	United States Patent and Trademark Office	11318088	May 3, 2022
‌ US Patent 9458169 Crystalline forms of therapeutic compounds and uses thereof	Patent 9458169 was granted and assigned to Kala Pharmaceuticals on October, 2016 by the United States Patent and Trademark Office.	Kala Pharmaceuticals	Kala Pharmaceuticals	United States Patent and Trademark Office	9458169	October 4, 2016
‌ US Patent 9790232 Crystalline forms of therapeutic compounds and uses thereof	Patent 9790232 was granted and assigned to Kala Pharmaceuticals on October, 2017 by the United States Patent and Trademark Office.	Kala Pharmaceuticals	Kala Pharmaceuticals	United States Patent and Trademark Office	9790232	October 17, 2017
‌ US Patent 9827248 Therapeutic compounds and uses thereof	Patent 9827248 was granted and assigned to Kala Pharmaceuticals on November, 2017 by the United States Patent and Trademark Office.	Kala Pharmaceuticals	Kala Pharmaceuticals	United States Patent and Trademark Office	9827248	November 28, 2017
‌ US Patent 9353122 Therapeutic compounds and uses thereof	Patent 9353122 was granted and assigned to Kala Pharmaceuticals on May, 2016 by the United States Patent and Trademark Office.	Kala Pharmaceuticals	Kala Pharmaceuticals	United States Patent and Trademark Office	9353122	May 31, 2016
‌ US Patent 8354476 Functionalized poly(ether-anhydride) block copolymers	Patent 8354476 was granted and assigned to Kala Pharmaceuticals on January, 2013 by the United States Patent and Trademark Office.		Kala Pharmaceuticals	United States Patent and Trademark Office	8354476	January 15, 2013
‌ US Patent 9877970 Therapeutic compounds and uses thereof	Patent 9877970 was granted and assigned to Kala Pharmaceuticals on January, 2018 by the United States Patent and Trademark Office.	Kala Pharmaceuticals	Kala Pharmaceuticals	United States Patent and Trademark Office	9877970	January 30, 2018
‌ US Patent 9393213 Nanocrystals, compositions, and methods that aid particle transport in mucus	Patent 9393213 was granted and assigned to Kala Pharmaceuticals on July, 2016 by the United States Patent and Trademark Office.		Kala Pharmaceuticals	United States Patent and Trademark Office	9393213	July 19, 2016
‌ US Patent 9393212 Nanocrystals, compositions, and methods that aid particle transport in mucus	Patent 9393212 was granted and assigned to Kala Pharmaceuticals on July, 2016 by the United States Patent and Trademark Office.		Kala Pharmaceuticals	United States Patent and Trademark Office	9393212	July 19, 2016
‌ US Patent 9725451 Meropenem derivatives and uses thereof	Patent 9725451 was granted and assigned to Kala Pharmaceuticals on August, 2017 by the United States Patent and Trademark Office.	Kala Pharmaceuticals	Kala Pharmaceuticals	United States Patent and Trademark Office	9725451	August 8, 2017
‌ US Patent 10059693 Urea derivatives and uses thereof	Patent 10059693 was granted and assigned to Kala Pharmaceuticals on August, 2018 by the United States Patent and Trademark Office.	Kala Pharmaceuticals	Kala Pharmaceuticals	United States Patent and Trademark Office	10059693	August 28, 2018
‌ US Patent 9695184 Therapeutic compounds and uses thereof	Patent 9695184 was granted and assigned to Kala Pharmaceuticals on July, 2017 by the United States Patent and Trademark Office.	Kala Pharmaceuticals	Kala Pharmaceuticals	United States Patent and Trademark Office	9695184	July 4, 2017
‌ US Patent 9688688 Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof	Patent 9688688 was granted and assigned to Kala Pharmaceuticals on June, 2017 by the United States Patent and Trademark Office.	Kala Pharmaceuticals	Kala Pharmaceuticals	United States Patent and Trademark Office	9688688	June 27, 2017
‌ US Patent 9802922 Urea derivatives and uses thereof	Patent 9802922 was granted and assigned to Kala Pharmaceuticals on October, 2017 by the United States Patent and Trademark Office.	Kala Pharmaceuticals	Kala Pharmaceuticals	United States Patent and Trademark Office	9802922	October 31, 2017
‌ US Patent 10160765 Crystalline forms of therapeutic compounds and uses thereof	Patent 10160765 was granted and assigned to Kala Pharmaceuticals on December, 2018 by the United States Patent and Trademark Office.	Kala Pharmaceuticals	Kala Pharmaceuticals	United States Patent and Trademark Office	10160765	December 25, 2018
‌ US Patent 9861634 Therapeutic compounds and uses thereof	Patent 9861634 was granted and assigned to Kala Pharmaceuticals on January, 2018 by the United States Patent and Trademark Office.	Kala Pharmaceuticals	Kala Pharmaceuticals	United States Patent and Trademark Office	9861634	January 9, 2018
‌ US Patent 10174022 1-amino-triazolo(1,5-A)pyridine-substituted urea derivative and uses thereof	Patent 10174022 was granted and assigned to Kala Pharmaceuticals on January, 2019 by the United States Patent and Trademark Office.	Kala Pharmaceuticals	Kala Pharmaceuticals	United States Patent and Trademark Office	10174022	January 8, 2019
‌ US Patent 9890173 Crystalline forms of therapeutic compounds and uses thereof	Patent 9890173 was granted and assigned to Kala Pharmaceuticals on February, 2018 by the United States Patent and Trademark Office.	Kala Pharmaceuticals	Kala Pharmaceuticals	United States Patent and Trademark Office	9890173	February 13, 2018
‌ US Patent 9212145 Urea derivatives and uses thereof	Patent 9212145 was granted and assigned to Kala Pharmaceuticals on December, 2015 by the United States Patent and Trademark Office.	Kala Pharmaceuticals	Kala Pharmaceuticals	United States Patent and Trademark Office	9212145	December 15, 2015
‌ US Patent 11369611 Therapeutic compounds and uses thereof	Patent 11369611 was granted and assigned to Kala Pharmaceuticals on June, 2022 by the United States Patent and Trademark Office.	Kala Pharmaceuticals	Kala Pharmaceuticals	United States Patent and Trademark Office	11369611	June 28, 2022
‌ US Patent 9353123 Therapeutic compounds and uses thereof	Patent 9353123 was granted and assigned to Kala Pharmaceuticals on May, 2016 by the United States Patent and Trademark Office.	Kala Pharmaceuticals	Kala Pharmaceuticals	United States Patent and Trademark Office	9353123	May 31, 2016
‌ US Patent 11401260 Biochemical binding of RET9 and VEGFR2 inhibitors	Patent 11401260 was granted and assigned to Kala Pharmaceuticals on August, 2022 by the United States Patent and Trademark Office.	Kala Pharmaceuticals	Kala Pharmaceuticals	United States Patent and Trademark Office	11401260	August 2, 2022
‌ US Patent 11352343 Urea derivatives and uses thereof	Patent 11352343 was granted and assigned to Kala Pharmaceuticals on June, 2022 by the United States Patent and Trademark Office.	Kala Pharmaceuticals	Kala Pharmaceuticals	United States Patent and Trademark Office	11352343	June 7, 2022
‌ US Patent 9833453 Therapeutic compounds and uses thereof	Patent 9833453 was granted and assigned to Kala Pharmaceuticals on December, 2017 by the United States Patent and Trademark Office.	Kala Pharmaceuticals	Kala Pharmaceuticals	United States Patent and Trademark Office	9833453	December 5, 2017

Results per page:

27 results

0 selected

27 results

0 selected